{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:12:24Z","timestamp":1794622344145,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate the specific relationship between cutaneous allodynia (CA) and the percentages of body fat (BF) and abdominal fat in migraineurs. Additionally, we compared serum levels of inflammatory biomarkers in patients with and without CA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Excess abdominal fat might facilitate progressive changes in nociceptive thresholds causing central sensitization, clinically reflected as CA, which could drive migraine progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This prospective cohort study included 80 patients with migraine (mean age 39\u2009years, 81.2% female) and 39 non-migraine controls. We analysed each participant\u2019s height, body weight, and body mass index (BMI). The amount and distribution of BF was also assessed by air displacement plethysmography (ADP) and ViScan, respectively. We analysed serum levels of markers of inflammation, during interictal periods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We studied 52 patients with episodic migraine (EM) and 28 with chronic migraine (CM). Of the 80 patients, 53 (53.8%) had CA. Migraineurs with CA had a higher proportion of abdominal fat values than patients without CA (<jats:italic>p<\/jats:italic>\u2009=\u20090.04). The independent risk factors for CA were the use of migraine prophylaxis (OR 3.26, 95% CI [1.14 to 9.32]; <jats:italic>p<\/jats:italic>\u2009=\u20090.03), proportion of abdominal fat (OR 1.13, 95% CI [1.01 to 1.27]; <jats:italic>p\u2009=<\/jats:italic>\u00a00.04), and presence of sleep disorders (OR 1.13, 95% CI [00.01 to 1.27]; <jats:italic>p<\/jats:italic>\u2009=\u20090.04). The concordance correlation coefficient between the ADP and BMI measurements was 0.51 (0.3681 to 0.6247). CA was not correlated with the mean plasma levels of inflammatory biomarkers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There is a relation between excess abdominal fat and CA. Abdominal obesity might contribute to the development of central sensitization in migraineurs, leading to migraine chronification.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-020-1082-0","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T15:03:04Z","timestamp":1580828584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Excess abdominal fat is associated with cutaneous allodynia in individuals with migraine: a prospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Ane","family":"M\u00ednguez-Olaondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Mart\u00ednez-Valbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Fr\u00fchbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosario","family":"Luquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00ednez-Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-0036","authenticated-orcid":false,"given":"Pablo","family":"Irimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"key":"1082_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","volume":"84","author":"RB Lipton","year":"2015","unstructured":"Lipton RB, Fanning KM, Serrano D, Reed ML, Cady R, Buse DC (2015) Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 84:688\u2013695","journal-title":"Neurology."},{"key":"1082_CR2","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1526-4610.2006.00577.x","volume":"46","author":"ME Bigal","year":"2006","unstructured":"Bigal ME, Lipton RB (2006) Modifiable risk factors for migraine progression. Headache. 46:1334\u20131343","journal-title":"Headache."},{"key":"1082_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455\u2013464","journal-title":"Nat Rev Neurol"},{"key":"1082_CR4","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1093\/brain\/awt251","volume":"136","author":"MA Louter","year":"2013","unstructured":"Louter MA, Bosker JE, van Oosterhout WP, van Zwet EW, Zitman FG, Ferrari MD et al (2013) Cutaneous allodynia as a predictor of migraine chronification. Brain. 136:3489\u20133496","journal-title":"Brain."},{"key":"1082_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/j.1532-2149.2012.00230.x","volume":"17","author":"HL Rossi","year":"2013","unstructured":"Rossi HL, Luu AK, DeVilbiss JL, Recober A (2013) Obesity increases nociceptive activation of the trigeminal system. Eur J Pain 17:649\u2013653","journal-title":"Eur J Pain"},{"key":"1082_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/fnl.13.65","volume":"9","author":"A Recober","year":"2014","unstructured":"Recober A, Peterlin BL (2014) Migraine and obesity: moving beyond BMI. Future Neurol 9:37\u201340","journal-title":"Future Neurol"},{"key":"1082_CR7","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.2337\/dc14-0937","volume":"37","author":"J G\u00f3mez-Ambrosi","year":"2014","unstructured":"G\u00f3mez-Ambrosi J, Catal\u00e1n V, Rodr\u00edguez A, Andrada P, Ram\u00edrez B, Ib\u00e1\u00f1ez P et al (2014) Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care 37:2813\u20132821","journal-title":"Diabetes Care"},{"key":"1082_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1160\/TH06-02-0079","volume":"95","author":"J Gomez-Ambrosi","year":"2006","unstructured":"Gomez-Ambrosi J, Salvador J, Silva C, Pastor C, Rotellar F, Gil MJ et al (2006) Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin. Thromb Haemost 95:991\u2013996","journal-title":"Thromb Haemost"},{"key":"1082_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/MCO.0b013e32830b5f23","volume":"11","author":"SY Lee","year":"2008","unstructured":"Lee SY, Gallagher D (2008) Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care 11:566\u2013572","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1082_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ijo.2011.100","volume":"36","author":"J Gomez-Ambrosi","year":"2012","unstructured":"Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Millan D et al (2012) Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) 36:286\u2013294","journal-title":"Int J Obes (Lond)"},{"key":"1082_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s10194-018-0895-6","volume":"19","author":"L Di Renzo","year":"2018","unstructured":"Di Renzo L, Cammarano A, De Lorenzo A (2018) The missclassification of obesity affects the course of migraine. J Headache Pain 19:63","journal-title":"J Headache Pain"},{"key":"1082_CR12","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1212\/01.wnl.0000310645.31020.b1","volume":"70","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D et al (2008) Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 70:1525\u20131533","journal-title":"Neurology."},{"key":"1082_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.atherosclerosis.2005.03.010","volume":"183","author":"DB Panagiotakos","year":"2005","unstructured":"Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C (2005) The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis. 183:308\u2013315","journal-title":"Atherosclerosis."},{"key":"1082_CR14","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","volume":"28","author":"Y Kawasaki","year":"2008","unstructured":"Kawasaki Y, Zhang L, Cheng JK, Ji RR (2008) Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28:5189\u20135194","journal-title":"J Neurosci"},{"key":"1082_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jchemneu.2014.09.002","volume":"61\u201362","author":"N Wada","year":"2014","unstructured":"Wada N, Hirako S, Takenoya F, Kageyama H, Okabe M, Shioda S (2014) Leptin and its receptors. J Chem Neuroanat 61\u201362:191\u2013199","journal-title":"J Chem Neuroanat"},{"key":"1082_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ana.21211","volume":"63","author":"RB Lipton","year":"2008","unstructured":"Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML et al (2008) Cutaneous allodynia in the migraine population. Ann Neurol 63:148\u2013158","journal-title":"Ann Neurol"},{"key":"1082_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2377-10-126","volume":"10","author":"G Coppola","year":"2010","unstructured":"Coppola G, Curra A, Di Lorenzo C, Parisi V, Gorini M, Sava SL et al (2010) Abnormal cortical responses to somatosensory stimulation in medication-overuse headache. BMC Neurol 10:126","journal-title":"BMC Neurol"},{"key":"1082_CR18","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1\u2013211","DOI":"10.1177\/0333102417738202"},{"key":"1082_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0304-3959(00)00305-5","volume":"88","author":"WF Stewart","year":"2000","unstructured":"Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN (2000) Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 88:41\u201352","journal-title":"Pain."},{"key":"1082_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12:963\u2013974","journal-title":"Qual Life Res"},{"key":"1082_CR21","unstructured":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1\u2013452"},{"key":"1082_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","volume":"22","author":"KM Flegal","year":"1998","unstructured":"Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22:39\u201347","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1082_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ijo.2010.5","volume":"34","author":"DO Okorodudu","year":"2010","unstructured":"Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ et al (2010) Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) 34:791\u2013799","journal-title":"Int J Obes (Lond)"},{"key":"1082_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.0006-341X.2000.00324.x","volume":"56","author":"LI Lin","year":"2000","unstructured":"Lin LI (2000) A note on the concordance correlation coefficient. Biometrics. 56:324\u2013325","journal-title":"Biometrics."},{"key":"1082_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3748\/wjg.v22.i2.681","volume":"22","author":"A De Lorenzo","year":"2016","unstructured":"De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L (2016) New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol 22:681\u2013703","journal-title":"World J Gastroenterol"},{"key":"1082_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/ijpo.245","volume":"10","author":"A Verrotti","year":"2015","unstructured":"Verrotti A, Carotenuto M, Altieri L, Parisi P, Tozzi E, Belcastro V et al (2015) Migraine and obesity: metabolic parameters and response to a weight loss programme. Pediatr Obes 10:220\u2013225","journal-title":"Pediatr Obes"},{"key":"1082_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0333102414544978","volume":"35","author":"IS Santos","year":"2015","unstructured":"Santos IS, Goulart AC, Passos VM, Molina Mdel C, Lotufo PA, Bensenor IM (2015) Obesity, abdominal obesity and migraine: a cross-sectional analysis of ELSA-Brasil baseline data. Cephalalgia. 35:426\u2013436","journal-title":"Cephalalgia."},{"key":"1082_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1526-4610.2009.01459.x","volume":"50","author":"BL Peterlin","year":"2010","unstructured":"Peterlin BL, Rosso AL, Rapoport AM, Scher AI (2010) Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. 50:52\u201362","journal-title":"Headache."},{"key":"1082_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11916-018-0691-7","volume":"22","author":"I Rainero","year":"2018","unstructured":"Rainero I, Govone F, Gai A, Vacca A, Rubino E (2018) Is migraine primarily a Metaboloendocrine disorder? Curr Pain Headache Rep 22:36","journal-title":"Curr Pain Headache Rep"},{"key":"1082_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/oby.2011.36","volume":"19","author":"J Gomez-Ambrosi","year":"2011","unstructured":"Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Gil MJ et al (2011) Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity (Silver Spring) 19:1439\u20131444","journal-title":"Obesity (Silver Spring)"},{"key":"1082_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"RR Ji","year":"2018","unstructured":"Ji RR, Nackley A, Huh Y, Terrando N, Maixner W (2018) Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 129:343\u2013366","journal-title":"Anesthesiology."},{"key":"1082_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0009-9120(02)00320-X","volume":"35","author":"J Gomez-Ambrosi","year":"2002","unstructured":"Gomez-Ambrosi J, Salvador J, Paramo JA, Orbe J, de Irala J, Diez-Caballero A et al (2002) Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 35:315\u2013320","journal-title":"Clin Biochem"},{"key":"1082_CR33","doi-asserted-by":"publisher","first-page":"E691","DOI":"10.1152\/ajpendo.00297.2015","volume":"309","author":"A Rodriguez","year":"2015","unstructured":"Rodriguez A, Ezquerro S, Mendez-Gimenez L, Becerril S, Fruhbeck G (2015) Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Endocrinol Metab 309:E691\u2013E714","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1082_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13311-017-0602-3","volume":"15","author":"LC Strother","year":"2018","unstructured":"Strother LC, Srikiatkhachorn A, Supronsinchai W (2018) Targeted Orexin and hypothalamic neuropeptides for migraine. Neurotherapeutics. 15:377\u2013390","journal-title":"Neurotherapeutics."},{"key":"1082_CR35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/0333102418825346","volume":"39","author":"DW Dodick","year":"2019","unstructured":"Dodick DW, Reed ML, Fanning KM, Munjal S, Alam A, Buse DC et al (2019) Predictors of allodynia in persons with migraine: results from the migraine in America symptoms and treatment (MAST) study. Cephalalgia. 39:873\u2013882","journal-title":"Cephalalgia."},{"key":"1082_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1129-2377-15-64","volume":"15","author":"M de Tommaso","year":"2014","unstructured":"de Tommaso M, Delussi M, Vecchio E, Sciruicchio V, Invitto S, Livrea P (2014) Sleep features and central sensitization symptoms in primary headache patients. J Headache Pain. 15:64","journal-title":"J Headache Pain."},{"key":"1082_CR37","first-page":"401487","volume":"2013","author":"E Fuller-Thomson","year":"2013","unstructured":"Fuller-Thomson E, Schrumm M, Brennenstuhl S (2013) Migraine and despair: factors associated with depression and suicidal ideation among Canadian Migraineurs in a population-based study. Depress Res Treat 2013:401487","journal-title":"Depress Res Treat"},{"key":"1082_CR38","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/0333102414532554","volume":"34","author":"MA Louter","year":"2014","unstructured":"Louter MA, Wardenaar KJ, Veen G, van Oosterhout WP, Zitman FG, Ferrari MD et al (2014) Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia. 34:1187\u20131192","journal-title":"Cephalalgia."},{"key":"1082_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s10194-015-0529-1","volume":"16","author":"SP Park","year":"2015","unstructured":"Park SP, Seo JG, Lee WK (2015) Osmophobia and allodynia are critical factors for suicidality in patients with migraine. J Headache Pain. 16:529","journal-title":"J Headache Pain."},{"key":"1082_CR40","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.0000000000003919","volume":"88","author":"B Gelaye","year":"2017","unstructured":"Gelaye B, Sacco S, Brown WJ, Nitchie HL, Ornello R, Peterlin BL (2017) Body composition status and the risk of migraine: a meta-analysis. Neurology. 88:1795\u20131804","journal-title":"Neurology."},{"key":"1082_CR41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1212\/01.wnl.0000225052.35019.f9","volume":"67","author":"ME Bigal","year":"2006","unstructured":"Bigal ME, Lipton RB (2006) Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 67:252\u2013257","journal-title":"Neurology."},{"key":"1082_CR42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1046\/j.1526-4610.2002.02202.x","volume":"42","author":"M Lemstra","year":"2002","unstructured":"Lemstra M, Stewart B, Olszynski WP (2002) Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache. 42:845\u2013854","journal-title":"Headache."},{"key":"1082_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1468-1331.2012.03771.x","volume":"20","author":"A Verrotti","year":"2013","unstructured":"Verrotti A, Agostinelli S, D'Egidio C, Di Fonzo A, Carotenuto M, Parisi P et al (2013) Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol 20:394\u2013397","journal-title":"Eur J Neurol"},{"key":"1082_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1212\/WNL.0b013e318212ab1e","volume":"76","author":"DS Bond","year":"2011","unstructured":"Bond DS, Vithiananthan S, Nash JM, Thomas JG, Wing RR (2011) Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. 76:1135\u20131138","journal-title":"Neurology."},{"key":"1082_CR45","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1177\/0333102411413162","volume":"31","author":"V Novack","year":"2011","unstructured":"Novack V, Fuchs L, Lantsberg L, Kama S, Lahoud U, Horev A et al (2011) Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 31:1336\u20131342","journal-title":"Cephalalgia."},{"key":"1082_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/head.12297","volume":"54","author":"NC Chai","year":"2014","unstructured":"Chai NC, Bond DS, Moghekar A, Scher AI, Peterlin BL (2014) Obesity and headache: part II--potential mechanism and treatment considerations. Headache. 54:459\u2013471","journal-title":"Headache."}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-020-1082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-020-1082-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-020-1082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:06:32Z","timestamp":1612310792000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-020-1082-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1186\/s10194-020-1082-0","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,4]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"See \u201c\u201d section above.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"See \u201c\u201d section above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ane M\u00ednguez-Olaondo, Iv\u00e1n Mart\u00ednez-Valbuena, Eduardo Mart\u00ednez-Vila, Sonia Romero and Gema Fr\u00fchbeck declare that they have no competing interests. Mar\u00eda Rosario Luquin have received honoraria from TEVA, Zambon, AbbVie and Bial for activities unrelated to the work submitted. Pablo Irimia has received honoraria from Allergan, Novartis, Lilly and Teva Pharmaceuticals as a consultant and speaker.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}